Garuda Aerospace inks pact with Narayana Health, to ferry medical supplies

Drone manufacturer Garuda Aerospace has joined hands with healthcare provider Narayana Health towards transporting of bio-medical supplies using their 'Sanjeevani' drone, the company said on Friday. The partnership between the two aims to ensure faster delivery of medical supplies including samples for diagnosis during challenging conditions. "With the help of Garuda Aerospace's Sanjeevani drone, Narayana Health will be able to transport bio-medical supplies quickly, ensuring patients receive timely diagnosis and treatments." Garuda Aerospace said. The drones would be able to provide emergency healthcare in remote and under served areas as well, it said. "Our aim is to improve access to critical medical supplies and support the delivery to patients in need and in times of emergency," Garuda Aerospace founder-CEO Agnishwar Jayaprakash said in a statement. On their association with Garuda Aerospace, Narayana Health Chairman Dr Devi Shetty said, "by partnering with Garuda Aerospace,
17-02-2023

Buy Narayana Hrudayalaya; target of Rs 965: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Narayana Hrudayalaya has recommended buy rating on the stock with a target price of Rs 965 in its research report dated February 11, 2023.
15-02-2023
Bigul

Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Please find enclosed herewith the transcript of the Earnings Call of the Company for the quarter and nine months ended 31st December 2022, held on 10th February 2023.
15-02-2023
Bigul

Narayana Hrudayalaya Ltd - 539551 - Audio Recording Of Earnings Call For The Quarter And Nine Months Ended 31St December 2022

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), please be informed that the Earnings Call of the Company for the quarter and nine months ended 31st December 2022, was held on 10th February 2023 and the Audio Recording w.r.t. the Earnings Call has been uploaded on the same day and is available on the website of the Company.
11-02-2023
Bigul

Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, enclosed Outcome of Investor/Analyst Meet.
10-02-2023
Bigul

Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed herewith the copy of the newspaper advertisement published on Friday, 10th February 2023 in English newspaper - Financial Express and Regional (Kannada) newspaper- Vijayavani.
10-02-2023
Bigul

National highway projects worth 11.23-lakh crore under implementation

Highest quantum of funds have been for NH projects in Maharashtra followed by Uttar Pradesh, Bihar, Karnataka and Kerala
09-02-2023
Bigul

Q3FY23 Quarterly Result Announced for Narayana Hrudayalaya Ltd.

Healthcare facilities firm Narayana Hrudayalaya announced Q3FY23 results: Consolidated Q3FY23: Total operating income was Rs 11,282 million for Q3FY23 as compared to Rs 9,598 million in the corresponding period of the previous year, reflecting an increase of 17.5% YoY and a decline of 1.2% QoQ. EBITDA stood at Rs 2,660 million, reflecting a margin of 23.6% as against Rs 1,819 million in Q3FY22, translating into YoY growth of 46.3% and QoQ degrowth of 3.2% respectively. PAT stood at Rs 1,539 million, reflecting a margin of 13.6% as compared to Rs 975 million in Q3FY22, translating into YoY growth of 57.7% and QoQ degrowth of 8.9% respectively. Consolidated 9MFY23: total operating income was Rs 33,032 million for 9MF23 as compared to Rs 27,606 million in 9MFY22 EBITDA of Rs 7,408 million for 9MFY23, reflecting a margin of 22.4% as against Rs 5,032 million in 9MFY22 PAT stood at Rs 4,333 million for 9MFY23, reflecting a margin of 13.1% as compared to Rs 2,732 million in 9MFY22. IND AS 116: Effective April 1, 2019, which resulted in Rs 118.6 million increase in EBITDA and increase of Rs 0.4 million in PAT for Q3FY23 and Rs 409.1 million increase in EBITDA and increase of Rs 8.4 million in PAT for 9MFY23 on a like-to-like basis. Total Borrowings less Cash & Bank Balance and Current Investments was Rs 2,142 million, representing a net debt to equity ratio of 0.11. (Out of which, borrowings worth US$ 33.3 million is foreign currency denominated). Commenting on the performance, Emmanuel Rupert, Managing Director and Group CEO, Narayana Hrudayalaya Limited, said, “Despite several holidays and festivals which affect patient footfall, the third quarter delivered steady performance supported by the growth in business across our flagship units, newer hospitals and improvement in payor mix. However, contributions from international patient footfall remain unaffected. Our Cayman unit managed to contribute to the overall performance despite the holiday season and we remain optimistic about the strong growth prospects of overseas business. We continue to strengthen our current position and grow our brand through several strategic initiatives that will drive our vision to offer integrated healthcare services to people across our core geographies.” Result PDF
09-02-2023
Bigul

Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Pursuant to Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Press Release for the Quarter and nine months ended 31st December 2022 and call invite to discuss the Company's performance on Friday, 10th February 2023 at 2:30 P.M. (IST).
08-02-2023
Bigul

Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Investor Presentation

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Investor Presentation for the Quarter and nine months ended 31st December 2022.
08-02-2023
Next Page
Close

Let's Open Free Demat Account